AMMI Canada Practice Point: Updated recommendations for treatment of adults with symptomatic COVID-19 in 2023-2024.

Autor: Grant JM; Divisions of Medical Microbiology and Infectious Diseases, University of British Columbia, Vancouver, British Columbia, Canada., Lam J; Division of Infectious Diseases, Department of Medicine, University of California, Los Angeles, California, USA., Goyal SV; Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada., Lother S; Sections of Infectious Diseases and Critical Care, University of Manitoba, Manitoba, Canada., Kassim SS; Department of Family Medicine, University of Manitoba, Manitoba, Canada., Lee SB; Division of Infectious Diseases, University of Saskatchewan, Saskatoon, Saskatchewan, Canada., Chan J; Division of Infectious Diseases and Immunology, Department of Medicine, NYU Grossman School of Medicine, New York, USA., Girouard G; Centre hospitalier universitaire Dr-Georges-L.-Dumont Vitalité Health Network, Moncton, New Brunswick, Canada., Barrett L; Infectious Diseases NSHA, Dalhousie University, Halifax, Nova Scotia, Canada., Takaya S; Division of Infectious Diseases, University of Saskatchewan, Saskatoon, Saskatchewan, Canada., Piszczek J; Department of Pharmacy, Royal Jubilee Hospital, Victoria, British Columbia, Canada., Vinh DC; Division of Infectious Diseases, Department of Medicine; Division of Medical Microbiology, Department of Laboratory Medicine, McGill University Health Centre, Montreal, Quebec, Canada., Findlater AR; Department of Medicine, McMaster University, Hamilton, Ontario, Canada., Saxinger L; Division of Infectious Diseases, University of Alberta, Edmonton, Alberta, Canada.

Publikováno v: Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada [J Assoc Med Microbiol Infect Dis Can] 2024 Jan 16; Vol. 8 (4), pp. 245-252. Date of Electronic Publication: 2024 Jan 16 (Print Publication: 2024).